In addition to the pain they inflict on individuals, noncommunicable diseases (NCDs) have substantial economic consequences. When people die prematurely or become disabled, the losses spiral outward into society, resulting in lower productivity and missed opportunities. Low- and middle-income countries are projected to lose an estimated $21.3 trillion in economic output due to the cumulative effects of NCDs between 2011-2030.
Working with partners around the globe, RTI experts bring extensive knowledge of health economics, budgeting, and financing to help countries prevent and manage NCDs. RTI offers decades of experience developing and applying analytical tools and modeling expertise to measure and improve the efficiency and cost-effectiveness of health care and interventions to prevent and manage NCDs.
Our researchers work to improve the health financing landscape for NCDs by identifying trends, gaps, and opportunities to finance ways to address major risk factors and reduce NCD prevalence, and to improve the quality of health service delivery and address financial barriers to health services. By analyzing the long-term costs and benefits of different NCD strategies and interventions, we help policy makers, health care industry leaders, and funding partners to know the value of good policy decisions, measure cost-effectiveness, improve health service delivery, and prioritize strategies with high returns on investment.